New prostate cancer drugs can give an extra 2 years to men

International trials of new drugs conducted in part by Northwestern University and Massachusetts General both succeeded in delaying the excruciating and deadly spread of prostate cancer in men.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Publication date: Available online 14 November 2018Source: European Journal of RadiologyAuthor(s): Alireza Aminsharifi, Rajan T. Gupta, Efrat Tsivian, Sitharthan Sekar, Christina Sze, Thomas J. PolascikAbstractPurposeTo introduce and assess the efficacy of a reduced core targeted (RCT) biopsy template (image-targeted + laterally directed sextant biopsy) to detect clinically-significant cancer in patients with elevated PSA and a previous negative biopsy or on active surveillance. The performance and added value of either targeted alone vs random sextant vs combined biopsy template was appraised.MethodsData fro...
Source: European Journal of Radiology - Category: Radiology Source Type: research
CONCLUSIONS High-level expression of KIF22 was related to both tumor progression and adverse clinical outcome. For this reason, KIF22 may become a potential prognostic factor for PCa. PMID: 30427826 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
Publication date: Available online 6 November 2018Source: Journal of Bone OncologyAuthor(s): Stella D'Oronzo, Robert Coleman, Janet Brown, Francesco SilvestrisAbstractBone metastases (BM) are a common complication of cancer, whose management often requires a multidisciplinary approach. Despite the recent therapeutic advances, patients with BM may still experience skeletal-related events and symptomatic skeletal events, with detrimental impact on quality of life and survival.A deeper knowledge of the mechanisms underlying the onset of lytic and sclerotic BM has been acquired in the last decades, leading to the development o...
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
Interview with Anthony D'Amico, MD, PhD, author of Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality
Source: JAMA Specialty Journals Author Interviews - Category: General Medicine Source Type: podcasts
Abstract Background: Cancer survivors suffer from many comorbid conditions even after the cure of their cancers beyond 5 years. We explored the differences in the association of comorbid conditions between the cancer survivors and patients without cancer. Methods: Electronic medical records of 280 adult cancer survivors and 280 age-matched patients without cancer in our suburban internal medicine office were reviewed. Results: Mean age of the cancer survivors was 72.5 ± 13.1 years, and the age of the patients without cancer was 72.5 ± 12.8 years. The number of male cancer survivors was sign...
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Tags: J Clin Med Res Source Type: research
This article reflects the aspects that are most influential on daily practice. A brief summary of 3 ancillary commercially available genomic tests is also provided.
Source: Surgical Pathology Clinics - Category: Pathology Authors: Source Type: research
Morteza Esmaeili, Nassim Tayari, Tom Scheenen, Mattijs Elschot, Elise Sandsmark, Helena Bertilsson, Arend Heerschap, Kirsten M. Seln æs, Tone F. Bathen
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
No abstract available
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: EDITORIAL Source Type: research
Authors: Kratiras Z, Gavazzi A, Belba A, Willis B, Chew S, Allen C, Amoroso P, Dasgupta P Abstract Robotic assisted radical prostatectomy is, currently, the most commonly utilized procedure for the treatment of localized prostate cancer. Image-guided surgical systems have been proposed in the literature as a valuable tool for the better utilization of the preoperative data in theatre. In this Phase 1 trial, we tested the feasibility and safety of a new, cutting - edge tablet based surgical imaging system designed for Robotic assisted radical prostatectomy (RARP). It utilizes the preoperative MRI images of the prost...
Source: Minerva Urologica e Nefrologica - Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research
More News: Cancer | Cancer & Oncology | Health | Prostate Cancer